These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 716016)

  • 1. Effect of the antiplatelet drug dipyridamole (RAF) on leukocyte response to mechanical trauma.
    McIntire LV; Dewitz TS; Martin RR
    Trans Am Soc Artif Intern Organs; 1978; 24():310-4. PubMed ID: 716016
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphometric aspects of washed platelets and their differences in response to the action of dipyridamole and ASA/dipyridamole].
    González Utor AL; López Campos JL
    Sangre (Barc); 1987; 32(2):161-74. PubMed ID: 3616879
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity.
    Gresele P; Arnout J; Deckmyn H; Vermylen J
    Thromb Haemost; 1986 Feb; 55(1):12-8. PubMed ID: 3704998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect on various platelet parameters of dipyridamole (225 mg/day) acetylsalicylic acid (150 mg/day) and their combination in healthy volunteers].
    Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; de Pablo Molina J; Sánchez de la Cuesta F
    Med Clin (Barc); 1985 Nov; 85(18):743-5. PubMed ID: 4094486
    [No Abstract]   [Full Text] [Related]  

  • 5. Adenosine diphosphate (ADP)-induced alpha-granules release from platelets of native whole blood is reduced by ticlopidine but not by aspirin or dipyridamole.
    Pengo V; Boschello M; Marzari A; Baca M; Schivazappa L; Dalla Volta S
    Thromb Haemost; 1986 Oct; 56(2):147-50. PubMed ID: 3810554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: adenosine-dependent and adenosine-independent mechanisms.
    Colli S; Tremoli E
    J Lab Clin Med; 1991 Aug; 118(2):136-45. PubMed ID: 1649884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation.
    Serebruany V; Sabaeva E; Booze C; Atar OD; Eisert C; Hanley D;
    Thromb Haemost; 2009 Sep; 102(3):538-43. PubMed ID: 19718475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of thrombosis with antiplatelet drugs.
    Kahn SB
    Am Fam Physician; 1980 May; 21(5):166-8. PubMed ID: 7377074
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of dipyridamole on platelet adhesiveness. Preliminary report].
    Garcia AB; Silva Cazares JH; Ladron de Guevara HR
    Sangre (Barc); 1971; 16(1):32-8. PubMed ID: 5577369
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug utilization review: dipyridamole plus aspirin antiplatelet therapy.
    Crisp CB; Garrard EA
    Hosp Formul; 1985 Nov; 20(11):1175-7, 1180-1, 1185. PubMed ID: 10274573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dipyridamole on platelet function in cardiopulmonary bypass in pigs.
    Becker RM; Smith MR; Dobell AR
    Surg Forum; 1972; 23(0):169-70. PubMed ID: 4671064
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets.
    Zucker MB; Peterson J
    J Lab Clin Med; 1970 Jul; 76(1):66-75. PubMed ID: 5425364
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlled, double-blind trial of antiplatelet aggregating agents in vascular renal allograft rejection.
    Mathew TH; Hogan GP; Lewers DT; Bauer H; Maher JF; Schreiner GE
    Transplant Proc; 1971 Mar; 3(1):901-4. PubMed ID: 4937989
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet therapy.
    Turpie AG
    Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood platelet count and bubble oxygenators. Changes induced by the oral administration of dipyridamole].
    Calafiore AM; Bosco G; Santarelli P; Scipioni G; Di Vincenzo V; Santarelli G; Liberi G; Acciai N; Cappelletti L
    Minerva Cardioangiol; 1989 Apr; 37(4):179-84. PubMed ID: 2788835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of aspirin and dipyridamole on platelet functions in Macaca fascicularis].
    Wang ZG; Po HG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Aug; 5(4):240-5. PubMed ID: 6228318
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of dipyridamole and RA 233 on human platelet function in vitro.
    Rifkin PL; Zucker MB
    Thromb Diath Haemorrh; 1973 Jun; 29(3):694-700. PubMed ID: 4761835
    [No Abstract]   [Full Text] [Related]  

  • 18. New roles for an old drug: inhibition of gene expression by dipyridamole in platelet-leukocyte aggregates.
    Weyrich AS; Kraiss LW; Prescott SM; Zimmerman GA
    Trends Cardiovasc Med; 2006 Apr; 16(3):75-80. PubMed ID: 16546687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of dipyridamole (225 mg/day) and acetylsalicylic acid (150 mg/day) on various platelet parameters in non-complicated diabetes mellitus].
    Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; García Arnés J; de Pablo Molina J; Sánchez de la Cuesta F
    Med Clin (Barc); 1986 May; 86(17):712-5. PubMed ID: 3736161
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental and clinical studies on platelet function. 3. Effect of dipyridamole derivatives (RA 233 and VK 744) on human platelet function in vitro and animal studies in the rabbit (author's transl)].
    Koike K
    Rinsho Ketsueki; 1973 Dec; 14(12):1154-62. PubMed ID: 4799955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.